EP 1809298 A2 20070725 - NEUROPROTECTIVE SPIROSTENOL PHARMACEUTICAL COMPOSITIONS
Title (en)
NEUROPROTECTIVE SPIROSTENOL PHARMACEUTICAL COMPOSITIONS
Title (de)
NEUROPROTEKTIVE PHARMAZEUTISCHE SPIROSTENOL-ZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES NEUROPROTECTRICES CONTENANT DU SPIROSTENOL
Publication
Application
Priority
- US 2005037023 W 20051014
- US 61869604 P 20041014
- US 3153805 A 20050107
Abstract (en)
[origin: WO2006044665A2] The present invention relates to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a disorder or disease related to, or the symptoms associated with a neurodegenerative disorder such as neurotoxicity or a neuropathology in a subject, particularly to beta-amyloid-induced neurotoxicity and Alzheimer's disease. The invention further provides a method for inducing stem cell differentiation into neuronal cells, by administering to the patient a therapeutically effective amount of a compound of the invention.
IPC 8 full level
A01N 45/00 (2006.01); A61K 31/56 (2006.01); A61K 31/58 (2006.01); A61K 31/585 (2006.01); A61K 31/59 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/56 (2013.01); A61K 31/58 (2013.01); A61K 31/585 (2013.01); A61K 31/59 (2013.01); A61P 9/00 (2017.12); A61P 25/00 (2017.12); A61P 25/04 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/22 (2017.12); A61P 25/28 (2017.12); A61P 31/22 (2017.12)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006044665 A2 20060427; WO 2006044665 A3 20070705; AU 2005295617 A1 20060427; CA 2584333 A1 20060427; EP 1809298 A2 20070725; EP 1809298 A4 20080618; JP 2008516972 A 20080522
DOCDB simple family (application)
US 2005037023 W 20051014; AU 2005295617 A 20051014; CA 2584333 A 20051014; EP 05812949 A 20051014; JP 2007536942 A 20051014